Ming J Poi (Ming Poi)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Multiple Myeloma

Top Venues

Molecular carcinogenesis

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ernest Duah, Nathan D Seligson, Avinash K Persaud, Quynh Dam, Navjot Pabla, James W Rocco, Junan Li, Ming J Poi
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas. Molecular carcinogenesis (2023)
Katharine A Collier, Hugo Valencia, Herbert Newton, Erinn M Hade, Douglas W Sborov, Robert Cavaliere, Ming J Poi, Mitch A Phelps, Sophia G Liva, Christopher C Coss, Jiang Wang, Soun Khountham, J Paul Monk, Charles L Shapiro, Richard L Piekarz, Craig C Hofmeister, D Bradley Welling, Amir Mortazavi
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies. Cancer chemotherapy and pharmacology 87 (5) (2021)
Avinash K Persaud, Junan Li, Jasmine A Johnson, Nathan Seligson, Douglas W Sborov, Ernest Duah, Yu Kyoung Cho, Danxin Wang, Mitch A Phelps, Craig C Hofmeister, Ming J Poi
XRCC1-mediated DNA repair is associated with progression-free survival of multiple myeloma patients after autologous stem cell transplant. Molecular carcinogenesis 58 (12) (2019)